Product NDC: | 54531-100 |
Proprietary Name: | Minocin |
Non Proprietary Name: | minocycline hydrochloride |
Active Ingredient(s): | 100 mg/1 & nbsp; minocycline hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54531-100 |
Labeler Name: | Rempex Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050444 |
Marketing Category: | NDA |
Start Marketing Date: | 20130419 |
Package NDC: | 54531-100-01 |
Package Description: | 10 INJECTION in 1 CARTON (54531-100-01) |
NDC Code | 54531-100-01 |
Proprietary Name | Minocin |
Package Description | 10 INJECTION in 1 CARTON (54531-100-01) |
Product NDC | 54531-100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | minocycline hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20130419 |
Marketing Category Name | NDA |
Labeler Name | Rempex Pharmaceuticals, Inc. |
Substance Name | MINOCYCLINE HYDROCHLORIDE |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |